Efficacy Results

Related by string. * EFFICACY . efficacy : primary efficacy endpoint . secondary efficacy endpoints . antimicrobial efficacy . preclinical efficacy . primary efficacy endpoints / resulted . results . result . resulting . RESULTS : EXECUTED THE RESULTS MAY . First Quarter Results . RECORD SIMULATED RESULTS DO . PERSONAL INJURY RESULTING DIRECTLY . RESULTS HAVE CERTAIN INHERENT * *

Related by context. Frequent words. (Click for all words.) 72 Pivotal Phase III 72 Tolerability 71 FDA Accepts 71 Pivotal Trial 71 Initiate Phase 71 Completes Enrollment 71 Clinical Trial Results 71 Presents Positive 71 Phase III Trial 71 Pivotal Phase 70 Phase III Clinical Trial 70 Drug Candidate 69 Patient Enrollment 68 Patients Treated 68 Well Tolerated 68 Chronic Hepatitis C 68 Pulmonary Arterial Hypertension 68 Preclinical Data 68 Metastatic Melanoma 67 Panzem R 67 Epratuzumab 67 Study Demonstrates 67 FDA Clears 67 Diabetic Macular Edema 67 Initiates Phase 67 Overactive Bladder 66 Venous Thromboembolism 66 alvimopan 66 Metastatic Colorectal Cancer 66 Hypoactive Sexual Desire Disorder 65 Natalizumab 65 Aliskiren 65 Cholesterol Drug 65 Patients Undergoing 65 QNEXA 65 Boceprevir 65 Monotherapy 65 Elderly Patients 65 Low Dose 65 Amrubicin 65 Pirfenidone 65 Benign Prostatic Hyperplasia 65 Entereg R 64 Inc Therapeutic Competitors 64 Heart Failure Patients 64 Complete Response 64 Generic Version 64 Significantly Reduces 64 FDA Clearance 64 Extended Release 64 Recombinant Human 64 Vandetanib 64 Fibrillex TM 64 Eltrombopag 64 Etanercept 64 Gemzar ® 63 Reduces Risk 63 Immunogenicity 63 retinal vein occlusion 63 Phenoptin 63 TORISEL 63 Postmenopausal Women 63 Irinotecan 63 DOXIL 63 eltrombopag 63 Anika Therapeutics 63 Fidaxomicin 63 Prostate Cancer Patients 63 Phase IIIb 63 KRN# 63 Receives FDA Clearance 63 efficacy tolerability 63 Phase IIB 63 Neurodex 63 PROMACTA 63 PROCRIT 63 Shows Promise 63 forodesine 63 primary hypercholesterolemia 63 pseudobulbar affect PBA 62 Avanafil 62 Advanced Prostate Cancer 62 Ofatumumab 62 Thrombin 62 DDP# 62 romiplostim 62 Gastric Cancer 62 Phase Ib clinical 62 Chronic Heart Failure 62 J Am Coll 62 multicenter Phase 62 Diabetic Patients 62 Positive Opinion 62 Acute Coronary Syndromes 62 Factor VIIa 62 Bevacizumab 62 metastatic castration resistant 62 Phase 2b clinical trials 62 Ixempra 62 Boxed Warning 62 Clinical Study

Back to home page